Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dental sealer put to the test in root canal study

NCT ID NCT07642284

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 11, 2026 · Updated 4 times

Summary

This study compares a new version of a root canal sealing material (AH Plus Jet®) to the current version in people needing a root canal. About 130 adults will receive treatment on one or two teeth and be followed for two years to see if the tooth heals properly. The goal is to check if the new sealer works as well and is as safe as the existing one.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AH Plus Jet® Endodontic Sealer (a dental sealing material used during root canal treatment)
What this could lead to
If successful, this could show that the new formula is as safe and effective as the current sealer, giving dentists another option for root canal procedures.
What could go wrong
This is a small, early-stage study (130 participants) comparing two similar devices, so any differences may be minor. The results may not apply to all tooth types or complex cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 130 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult aged 18-75 at time of informed consent. 2. Subject willing to participate in the clinical investigation and able to understand the content of the clinical investigation. 3. Subject willing to return for follow-up visits. 4. Subject has signed and dated the informed consent form. 5. Subject in need of one or two primary root canal treatment on mature permanent anterior (incisor or canine) or premolar tooth. 6. Planned study tooth has a favorable prognosis for the next 2 years. Exclusion Criteria: 1. History of allergic reaction to epoxy resins or amines or any of the other product components. 2. Subject has significant systemic health issues or chronic conditions (American Society of Anesthesiologists (ASA) class 3-6). 3. Known pregnancy or is breastfeeding at time of enrolment or at the RCT visit. 4. Subject unlikely to comply with investigational procedures, as judged by the Investigator. 5. Sign of sinus tract or gingival swelling in the planned study position. 6. Previous enrolment in the present clinical investigation. 7. Involvement in the planning and conduct of the clinical investigation (applies to both Dentsply Sirona personnel and the clinical investigation site). 8. Participation in another clinical investigation that may interfere with the present clinical investigation. 9. Subject experiencing an intraoperative condition that may interfere with the evaluation of the investigational root canal sealer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Root canal treatment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • New York University College of Dentistry

    RECRUITING

    New York, New York, 10010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.